WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PATIENTS FOR AFFORDABLE DRUGS, founded in 2016, is a community nonprofit in the Health Care sector that reported $2.3M in total revenue in fiscal year 2023. Revenue grew 14% year-over-year, indicating healthy expansion. The organization ran a surplus of $699K, a strong 30% operating margin.
THE PURPOSE OF PATIENTS FOR AFFORDABLE DRUGS IS TO PROMOTE HEALTH BY RAISING THE VOICES OF PATIENTS AND THEIR FAMILIES ON THE CAUSES OF HIGH DRUG PRICES AND TO HELP EDUCATE THEM ABOUT HOW THEY CAN BE A PART OF THE DISCUSSION AND WORK TO MAKE REFORMS TO THE US SYSTEM OF DRUG PRICING IN THE PRIVATE AND PUBLIC SECTORS.
GENERAL PROGRAM: THE GENERAL PROGRAM CONSISTS OF BUILDING A PATIENT-CENTERED COALITION THAT IS FINANCIALLY INDEPENDENT FROM ANY PHARMACEUTICAL INDUSTRY SUPPORT WITH A MISSION TO EDUCATE THE PUBLIC...
GENERAL PROGRAM: THE GENERAL PROGRAM CONSISTS OF BUILDING A PATIENT-CENTERED COALITION THAT IS FINANCIALLY INDEPENDENT FROM ANY PHARMACEUTICAL INDUSTRY SUPPORT WITH A MISSION TO EDUCATE THE PUBLIC, PATIENTS, AND KEY STAKEHOLDERS ABOUT BOTH THE REAL-LIFE CHALLENGES THAT PATIENTS FACE UNDER THE CURRENT DRUG DEVELOPMENT AND PRICING FRAMEWORK.
THE HOPEWELL FUND - IMPACT PROJECT: A GENERAL SUPPORT GRANT WITH A FOCUS ON RECRUITMENT AND TRAINING OF PATIENTS IN COLORADO, MICHIGAN AND VIRGINIA WHO TAKE HIGH COST PRESCRIPTION MEDICATION.
WEST HEALTH 2023 PILOT RECRUITMENT PROJECT: GRASSROOTS RECRUITMENT AND OUTREACH STRATEGY TO INCLUDE DEVELOPING AND IMPLEMENTING A PILOT RECRUITMENT STRATEGY WITH AN EMPHASIS ON IDENTIFYING AND...
WEST HEALTH 2023 PILOT RECRUITMENT PROJECT: GRASSROOTS RECRUITMENT AND OUTREACH STRATEGY TO INCLUDE DEVELOPING AND IMPLEMENTING A PILOT RECRUITMENT STRATEGY WITH AN EMPHASIS ON IDENTIFYING AND ENGAGING PATIENTS FROM COMMUNITIES WHO ARE DISPROPORTIONATELY HARMED BY HIGH DRUG PRICES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,318,017 | $2,028,313 | +0.1% |
| Expenses | $1,618,699 | $1,808,372 | -0.1% |
| Net Income | $699,318 | $219,941 | +2.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MERITH BASEY | EXECUTIVE DIRECTOR | 40 |
Officer
|
$225,650 | $7,569 | $233,219 |
| WENDY CHEW | CHIEF OPERATING OFFICER | 40 |
Officer
|
$180,513 | $21,818 | $202,331 |
| AUDREY BAKER | MEDIA & COMMUNICATIONS DIRECTOR | 20 |
Highest
|
$102,333 | $4,657 | $106,990 |
| DAVID MITCHELL | PRESIDENT/FOUNDER | 40 |
Officer
Director
|
$0 | $0 | $0 |
| CAL LAROCHE | TREASURER | 0.25 |
Officer
Director
|
$0 | $0 | $0 |
| CHARLES HURLEY | BOARD MEMBER | 0.25 |
Director
|
$0 | $0 | $0 |
| TOMI FADEYI-JONES | BOARD MEMBER | 0.25 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $2,318,017 | $1,618,699 | $1,271,094 | $699,318 |
| 2022 | $2,028,313 | $1,808,372 | $525,316 | $219,941 |
| 2021 | $603,423 | $1,142,425 | $344,432 | $-539,002 |
| 2020 | $876,388 | $1,085,568 | $903,107 | $-209,180 |
| 2019 | $1,654,194 | $1,003,929 | $1,061,488 | $650,265 |
| 2018 | $567,521 | $894,989 | $417,873 | $-327,468 |
Compare PATIENTS FOR AFFORDABLE DRUGS with other nonprofits in District of Columbia and across the country.